Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mayeux

Showing results (181-190 of 325) with videos related to

Pageof 33
Sort By:
Archives of Neurology|April 1, 1992
The Columbia University Scale for Psychopathology in Alzheimer's diseaseD P Devanand, L Miller, M Richards, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's diseaseH A Sackeim, I Prohovnik, J R Moeller, et al.
Annals of Neurology|November 1, 1996
Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndromeN Schupf, D Kapell, J H Lee, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen speciesS L Michael, N R Pumford, P R Mayeux, et al.
Neurology|August 24, 2005
Aggregation of vascular risk factors and risk of incident Alzheimer diseaseJ A Luchsinger, C Reitz, L S Honig, et al.
American Journal of Physiology. Renal Physiology|July 7, 2005
Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspasesManish M Tiwari, Robert W Brock, Judit K Megyesi, et al.
Neurology|July 1, 1990
Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's diseaseM R Palmert, M Usiak, R Mayeux, et al.
Aging (Milan, Italy)|June 1, 1995
A flexible system of detection for Alzheimer's disease and related dementiasB J Gurland, D E Wilder, J Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptorsJennifer L Shoemaker, Biny K Joseph, Michael B Ruckle, et al.
Neurology|January 13, 2006
Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacementG A Rippon, M X Tang, J H Lee, et al.
Pageof 33

Showing results (181-190 of 325) with videos related to

Sort By:
Pageof 33
Archives of Neurology|April 1, 1992
The Columbia University Scale for Psychopathology in Alzheimer's diseaseD P Devanand, L Miller, M Richards, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 1, 1993
Regional cerebral blood flow in mood disorders. II. Comparison of major depression and Alzheimer's diseaseH A Sackeim, I Prohovnik, J R Moeller, et al.
Annals of Neurology|November 1, 1996
Onset of dementia is associated with apolipoprotein E epsilon4 in Down's syndromeN Schupf, D Kapell, J H Lee, et al.
Hepatology (Baltimore, Md.)|July 1, 1999
Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen speciesS L Michael, N R Pumford, P R Mayeux, et al.
Neurology|August 24, 2005
Aggregation of vascular risk factors and risk of incident Alzheimer diseaseJ A Luchsinger, C Reitz, L S Honig, et al.
American Journal of Physiology. Renal Physiology|July 7, 2005
Disruption of renal peritubular blood flow in lipopolysaccharide-induced renal failure: role of nitric oxide and caspasesManish M Tiwari, Robert W Brock, Judit K Megyesi, et al.
Neurology|July 1, 1990
Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's diseaseM R Palmert, M Usiak, R Mayeux, et al.
Aging (Milan, Italy)|June 1, 1995
A flexible system of detection for Alzheimer's disease and related dementiasB J Gurland, D E Wilder, J Chen, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 20, 2005
The endocannabinoid noladin ether acts as a full agonist at human CB2 cannabinoid receptorsJennifer L Shoemaker, Biny K Joseph, Michael B Ruckle, et al.
Neurology|January 13, 2006
Familial Alzheimer disease in Latinos: interaction between APOE, stroke, and estrogen replacementG A Rippon, M X Tang, J H Lee, et al.
Pageof 33